ReP USP - Resultado da busca

Artigo de periodico
Effects of Eugenol and Dehydrodieugenol B from Nectandra leucantha against Lipopolysaccharide (LPS)-Induced Experimental Acute Lung Inflammation (2021)
Mernark, Marcia I Bittencourt; Pinheiro, Nathalia M; Silva, Rafael C. da; Ponci, Vitor; Banzato, Rosana; Pinheiro, Aruana J. M. C. R; Olivo, Clarice Rosa ; Tibério, Iolanda Fátima Lopes Calvo ; Lima Neto, Lidio G; Santana, Fernanda P. R
Source: Journal of natural products. Unidade: FM
Subjects: PULMÃO, INFLAMAÇÃO, FÁRMACOS, RATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MERNARK, Marcia I Bittencourt et al. Effects of Eugenol and Dehydrodieugenol B from Nectandra leucantha against Lipopolysaccharide (LPS)-Induced Experimental Acute Lung Inflammation. Journal of natural products, v. 84, n. 8, p. 2282-2294, 2021Tradução . . Disponível em: https://doi.org/10.1021/acs.jnatprod.1c00386. Acesso em: 29 maio 2024.
APA
Mernark, M. I. B., Pinheiro, N. M., Silva, R. C. da, Ponci, V., Banzato, R., Pinheiro, A. J. M. C. R., et al. (2021). Effects of Eugenol and Dehydrodieugenol B from Nectandra leucantha against Lipopolysaccharide (LPS)-Induced Experimental Acute Lung Inflammation. Journal of natural products, 84( 8), 2282-2294. doi:10.1021/acs.jnatprod.1c00386
NLM
Mernark MIB, Pinheiro NM, Silva RC da, Ponci V, Banzato R, Pinheiro AJMCR, Olivo CR, Tibério IFLC, Lima Neto LG, Santana FPR. Effects of Eugenol and Dehydrodieugenol B from Nectandra leucantha against Lipopolysaccharide (LPS)-Induced Experimental Acute Lung Inflammation [Internet]. Journal of natural products. 2021 ; 84( 8): 2282-2294.[citado 2024 maio 29 ] Available from: https://doi.org/10.1021/acs.jnatprod.1c00386
Vancouver
Mernark MIB, Pinheiro NM, Silva RC da, Ponci V, Banzato R, Pinheiro AJMCR, Olivo CR, Tibério IFLC, Lima Neto LG, Santana FPR. Effects of Eugenol and Dehydrodieugenol B from Nectandra leucantha against Lipopolysaccharide (LPS)-Induced Experimental Acute Lung Inflammation [Internet]. Journal of natural products. 2021 ; 84( 8): 2282-2294.[citado 2024 maio 29 ] Available from: https://doi.org/10.1021/acs.jnatprod.1c00386
Artigo de periodico
Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways (2020)
Santana, Fernanda P. R; Silva, Rafael C. da; Ponci, Vitor; Pinheiro, Aruana J. M. C. R; Olivo, Clarice Rosa ; Caperuto, Luciana C; Arantes-Costa, Fernanda M; Claudio, Samuel R; Ribeiro, Daniel A; Tibério, Iolanda Fátima Lopes Calvo
Source: Biochemical pharmacology. Unidade: FM
Subjects: ASMA, CAMUNDONGOS, PNEUMONIA, ÁCIDOS CARBOXÍLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTANA, Fernanda P. R et al. Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways. Biochemical pharmacology, v. 180, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2020.114175. Acesso em: 29 maio 2024.
APA
Santana, F. P. R., Silva, R. C. da, Ponci, V., Pinheiro, A. J. M. C. R., Olivo, C. R., Caperuto, L. C., et al. (2020). Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways. Biochemical pharmacology, 180. doi:10.1016/j.bcp.2020.114175
NLM
Santana FPR, Silva RC da, Ponci V, Pinheiro AJMCR, Olivo CR, Caperuto LC, Arantes-Costa FM, Claudio SR, Ribeiro DA, Tibério IFLC. Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways [Internet]. Biochemical pharmacology. 2020 ; 180[citado 2024 maio 29 ] Available from: https://doi.org/10.1016/j.bcp.2020.114175
Vancouver
Santana FPR, Silva RC da, Ponci V, Pinheiro AJMCR, Olivo CR, Caperuto LC, Arantes-Costa FM, Claudio SR, Ribeiro DA, Tibério IFLC. Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways [Internet]. Biochemical pharmacology. 2020 ; 180[citado 2024 maio 29 ] Available from: https://doi.org/10.1016/j.bcp.2020.114175
Artigo de periodico
Inhibition of MAPK and STAT3-SOCS3 by Sakuranetin Attenuated Chronic Allergic Airway Inflammation in Mice (2019)
Santana, Fernanda P. R; Silva, Rafael C. da; Grecco, Simone dos S; Pinheiro, Aruana J. M. C. R; Caperuto, Luciana C; Arantes-costa, Fernanda M; Claudio, Samuel R; Yoshizaki, Kelly; Macchione, Mariangela ; Tibério, Iolanda de Fátima Lopes Calvo
Source: Mediators of inflammation. Unidade: FM
Subjects: ASMA, HIPERSENSIBILIDADE RESPIRATÓRIA, LINFÓCITOS T, PROTEÍNAS QUINASES, FATORES DE TRANSCRIÇÃO, PROTEÍNAS DE TRANSPORTE, FLAVONOIDES, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTANA, Fernanda P. R et al. Inhibition of MAPK and STAT3-SOCS3 by Sakuranetin Attenuated Chronic Allergic Airway Inflammation in Mice. Mediators of inflammation, v. 2019, 2019Tradução . . Disponível em: https://doi.org/10.1155/2019/1356356. Acesso em: 29 maio 2024.
APA
Santana, F. P. R., Silva, R. C. da, Grecco, S. dos S., Pinheiro, A. J. M. C. R., Caperuto, L. C., Arantes-costa, F. M., et al. (2019). Inhibition of MAPK and STAT3-SOCS3 by Sakuranetin Attenuated Chronic Allergic Airway Inflammation in Mice. Mediators of inflammation, 2019. doi:10.1155/2019/1356356
NLM
Santana FPR, Silva RC da, Grecco S dos S, Pinheiro AJMCR, Caperuto LC, Arantes-costa FM, Claudio SR, Yoshizaki K, Macchione M, Tibério I de FLC. Inhibition of MAPK and STAT3-SOCS3 by Sakuranetin Attenuated Chronic Allergic Airway Inflammation in Mice [Internet]. Mediators of inflammation. 2019 ; 2019[citado 2024 maio 29 ] Available from: https://doi.org/10.1155/2019/1356356
Vancouver
Santana FPR, Silva RC da, Grecco S dos S, Pinheiro AJMCR, Caperuto LC, Arantes-costa FM, Claudio SR, Yoshizaki K, Macchione M, Tibério I de FLC. Inhibition of MAPK and STAT3-SOCS3 by Sakuranetin Attenuated Chronic Allergic Airway Inflammation in Mice [Internet]. Mediators of inflammation. 2019 ; 2019[citado 2024 maio 29 ] Available from: https://doi.org/10.1155/2019/1356356

USP Schools

ReP

Filtros

Authors

Subjects